An organelle-free fraction with the ability to synthesize citrus exocortis viroid (CEV) RNA was prepared from nuclei-rich samples taken from CEV-infected Gynura aurantiaca D.C. leaf tissue. This extraction was accomplished in the presence of the detergent sarkosyl. Characterization of the viroid synthetic reaction demonstrated that the solubilized complex retained the properties displayed by intact nuclei. These include optima of l mi-MnCl2, 10 mM-MgCI2 and 25 mM-(NH,)2SO,, as well as inhibition by ct-amanitin (90 ~ at 4 ~tg/ml) and by the chelators o-phenanthroline (78 at 5 mM) and hydroxyquinoline (45 ~ at 5 mi). Nucleic acid-binding agents such as ethidium bromide and actinomycin D showed a low, non-specific inhibition at relatively high concentrations. Sucrose gradient sedimentation analysis of the sarkosyl supernatant (SSN) components before and after the RNA synthesis showed that the bulk of the progeny remained associated with the viroid complex which sedimented faster than phenol-treated viroid RNA. A high percentage of the CEV RNA molecules migrated in electrophoresis as the circular form. This suggests that all elements necessary for the synthesis of viroid RNA and processing to circular structures are present in the SSN. This endorses the potential of these subnuclear preparations for the study of the processes involved in viroid replication.
INTRODUCTION
Viroids are low Mr RNA molecules that are transmissible in plants and sometimes produce disease symptoms. They consist of single-stranded, covalently closed, circular and linear RNA molecules (Riesner & Gross, 1985) . As they apparently do not code for any protein, replication appears strictly dependent upon host cell functions. Numerous reports have provided evidence for the nuclear location of viroid replication (Takahashi & Diener, 1975; Flores & Semancik, 1982; Semancik & Harper, 1984; Spiesmacher et al., 1985) , as well as for nuclear viroid accumulation (Diener, 1971 ; Semancik et al., 1976; Galindo et al., 1982 , Takahashi et al., 1982 .
The consistent and overwhelming evidence for ct-amanitin inhibition of viroid synthesis (Muhlbach & S3.nger, 1979; Flores & Semancik, 1982; Semancik & Harper, 1984; Yoshikawa & Takahashi, 1985; Lin & Semancik, 1985; Spiesmacher et al., 1985) endorses the involvement of a DNA-directed RNA polymerase II-like enzyme in the replication process. However evidence of low level traces of ~t-amanitin resistance in the synthesis of citrus exocortis viroid (CEV) (Semancik & Harper, 1984) , partial sequence homologies or similarities of the potato spindle tuber viroid (PSTV) sequence with DNA-dependent RNA polymerase I genes (Palukaitis & Zaitlin, 1987) and a reduction of PSTV synthesis by actinomycin D (Spiesmacher et al., 1985) have introduced the possible involvement of RNA polymerase I. These suggestive data, which for the most part are fragmentary, indicate the need for a more simplified viroid-replicating system for defining the specific parameters of viroid synthesis.
Several systems, such as cell suspension culture, protoplast and nuclei-rich fractions of 1" Present address: Centro de Investigaciones y Estudios Avanzados-IPN, Unidad Irapuato, Apdo. Postal 629, Irapuato, Gto. Mexico.
0000-8986 © 1989 SGM
differing purity have been used to study viroid replication. In all cases, viroid RNA synthesis represented a very low percentage of the total RNA synthesis in the complex systems. In order to reduce the background represented by host RNA synthesis the possibility of obtaining a subnuclear fraction enriched for the activity to synthesize viroid RNA was explored. This report presents data characterizing a viroid-replicating complex solubilized from nuclei-rich preparations from CEV-infected Gynura aurantiaca.
METHODS
Extraction of nucleic acids. Nucleic acids from CEV-infected G~ aurantiaca were extracted as described by Semancik & Weathers (1972) .
Nuclei-rich preparations. Nuclear fractions were obtained as described by Flores & Semancik (1982) . CEVinfected G. aurantiaca apex leaves (40 to 60 g) were homogenized using a Polytron homogenizer for 20 to 30 s in 5 g batches with 45 ml of extraction buffer (EB) containing 10 mM-Tricine-NaOH pH 8, 0.3 M-sucrose, 4 mM-CaC12 and 10 mM-2-mercaptoethanol. The homogenate was first filtered through eight layers of cheesecloth and the resulting filtrate through one layer of Miracloth. The filtrate was centrifuged for 10 min at 1000 g. The pellet was resuspended in 50 ml of EB containing 1 ~ Triton X-100 and allowed to stand on an ice bath for 10 rain. The suspension was centrifuged as before, the pellet was washed once with EB and then resuspended in a minimal volume of EB.
Sarkosyl supernatant (SSN) . Nuclear preparations were subjected to a very mild digestion with DNase I (10 units of RNase-free DNase I for 5 min at 4 °C) to avoid the formation of a gelatinous matrix from the lysed nuclei during the sarkosyl treatment. After DNase I treatment, 2 M-ammonium sulphate was added to give a final concentration of 100 mM and the sample was allowed to stand on ice for 10 min. Sarkosyl was then added to give a final concentration of 0.05~ and the sample was incubated on ice for another 10 min. The suspension was centrifuged for 30 min at 12000g and the supernatant was saved for further incubation for RNA synthesis.
Incubation for RNA synthesis. Nuclear fractions or SSN samples were incubated for RNA synthesis in a final volume of 1 ml containing 10 mM-Tricine-NaOH pH 8, 0.3 M-sucrose, 1 mM-MnCI2, 25 mM-ammonium sulphate, 10 mM-2-mercaptoethanol, 1.6 mM-CaCI2, 0.5 mM each of ATP, UTP and GTP, and 25 to 50 ~tCi of [~-3zp]CTP (Amersham; specific activity 3000 Ci/mmol). The samples were incubated at 18 °C for 1 h, after which the nucleic acids were extracted as described by Flores & Semancik (1982) . Total RNA synthesis was quantified as the incorporation of radioactive precursors into trichloroacetic acid (TCA)-precipitabte material.
PAGE. Nucleic acids were analysed by sequential PAGE under non-denaturing and denaturing (containing 8 M-urea) conditions, using silver staining (Rivera-Bustamante et al., 1986) and/or autoradiography for the denaturing gel. To quantify the incorporation of radioactive precursors into CEV molecules, the autoradiographs were scanned using an Ultroscan XL laser densitometer from LKB.
Sucrose gradient sedimentation. Sucrose gradients were 10 to 25 ~ or 10 to 40~ (w/v) in 10 mM-tricine-NaOH pH 8.0, 4 mM-CaC12 and 10 mM-2-mercaptoethanol. The gradients were subjected to rate velocity sedimentation by centrifuging for 10 to 13 h at 35000 to 40000 r.p.m, at 4 °C in a SW50.1 rotor. Fractions were collected by puncturing the bottom of the tube and were either incubated for RNA synthesis as described above, or phenolextracted and analysed by PAGE.
DNA, RNA andprotein determination. DNA content was determined using the diphenylamine method (Burton, 1955) , RNA content was determined by the orcinol procedure and the amount of protein was quantified by a modification of the Lowry method (Peterson, 1977) .
RESULTS

Release of a viroid-replicating complex from nuclear preparations
In an attempt to reduce the high background that host RNA synthesis represented in nucleirich CEV RNA-synthesizing preparations, various procedures for obtaining a subnuclear fraction were tested. The general protocol consisted of a procedure for tissue disruption, recovery of nuclei-rich fractions, and a simple scheme of differential centrifugation to produce two pellets, P1 a pellet produced after 1000g for 10 min and P2 produced after 12000g for 30 rain. SN, the soluble or supernatant fraction was produced after 12000g.
Mechanical disruption by sonication (Tata & Baker, 1974; Schumacher et al., 1983) and Virtis homogenization produced an incomplete and/or inconsistent homogenization resulting in nonuniform subfractions. Although high salt treatment has been successfully used to release transcriptional complexes in other systems (Gariglio et al., 1979) , RNA polymerases were inhibited to some extent under these conditions. More importantly, the optimum ionic strength * Determinations were made on nuclear fractions as the starting material, as described in Methods, and on the pellet (P1 + P2) and supernatant (SSN) after sarkosyl treatment, as described in the Results.
for CEV R N A synthesis has been reported (Semancik & Harper, 1984) to be at low salt concentration (0 to 100 mra-ammonium sulphate). The use of low concentration ammonium sulphate treatments released a small percentage of the activity for CEV R N A synthesis, leaving the bulk still associated with the complex P1 subfraction ( Fig. 1 a, lane 2) .
In an attempt to improve the release of the CEV R N A synthetic activity, sarkosyl at 0-05~ was included in the ammonium sulphate treatment. This treatment resulted in the release of most of the activity for synthesis of CEV R N A to the soluble fraction or SSN ( Fig. 1 b, lane 4) . Further investigations demonstrated that the sarkosyl treatment in the absence of ammonium sulphate effectively released the viroid-replicating complex for synthesis of CEV R N A . Therefore most of the succeeding experiments were performed with material obtained by exposure to sarkosyl alone.
Analysis of the material after sarkosyl treatment suggested that a specific subpopulation of nuclear components, which included viroid R N A , were preferentially released by the detergent treatment. Table 1 subfractions composed of the combined pellets and the supernatant. Most of the D N A ( > 95 ~) was recovered in the pellet. In addition, S D S -P A G E (data not shown) of the subfractions confirmed that most of the histone-like proteins remained in the pellet, suggesting that chromatin structures are still retained in the sedimentable material. On the other hand, nonhistone proteins and R N A were recovered in both fractions. CEV R N A was among the R N A species released to the SSN. The concomitant release of viroid R N A in the presence of the viroid-replicating complex might contribute to erroneous interpretations if the accumulated viroid could contribute to the viroid synthetic activity. However with the addition of high concentrations (10 to 100-fold) of purified CEV R N A , as well as other possible nucleic acid templates, including the avocado sunblotch viroid, a citrus viroid R N A mixture, cucumber mosaic virus R N A and calf thymus D N A , the CEV-synthesizing activity was not significantly affected. This result indicated that the viroid-replicating complex was assembled in vivo before the extraction and that no complexes were formed during or after the extraction.
The SSN was sedimented through sucrose gradients and the fractions collected were incubated under the optimum conditions for CEV R N A synthesis. The nucleic acids of each fraction were then phenol-extracted and analysed by P A G E . Fig. 2(a) demonstrates that the non-labelled (native) CEV in the SSN was found primarily in fractions 4 and 5 with densities of 1-0627 and 1.0574 (specific gravity) (Fig. 2b) complex in the SSN fraction * All reactions were performed at the standard conditions of 1 mM-MnCI2, 25 mM-(NH4)2SO,, 10 mM-TricineNaOH pH 8-0, 10 mM-2-mercaptoethanol.
t Percentages represent densitometer values for CEV obtained from autoradiographs as described in Methods.
Samples were preincubated at 37 °C for 30 min.
presence of radiolabelled CEV RNA (nascent CEV) was found at significantly higher densities in fractions 2 and 3 ( Fig. 2a) with values of 1-0734 and 1.0681 (Fig. 2b) . Phenol-extracted, deproteinized CEV RNA (naked CEV) sedimented in a sister tube at a density of 1.0521 (Fig.  2b) and thus is distinctly different from the structures containing the native and nascent CEV.
Characterization of CEV RNA synthesis in the SSN
Preincubation of the SSN with RNase or pronase dramatically inhibited the CEV synthesis reaction, whereas DNase I digestion did not affect the synthetic process (Table 2 ). In addition to the CEV RNA synthetic activity, host RNA polymerase activity was also detected in the SSN. However the synthesized host products displayed a high degree of size heterogeneity and, more importantly, no host component interfered with the resolution of CEV RNA in the sequential PAGE procedure employed.
To verify the relationships of the solubilized activity with previously reported systems using intact nuclei, biochemical characterization of the reaction was performed. Among the parameters tested with the solubilized activity were cation requirements, ionic strength and the effect of RNA polymerase inhibitors.
Cation requirements
Both CEV and total RNA synthesis displayed optima of 1 mM-MnC12 and 5 to 10 mM-MgC12. A pronounced difference in response to high cation concentrations between the two activities was noted. The total RNA synthesis activity displayed a sharp peak pattern with both cations whereas CEV RNA synthesis had a broader pattern suggesting a 'tolerance' to higher cation concentrations. This property permitted a reduction in the background of host RNA synthesis to between 40 and 50~ while still maintaining a 75 to 80~o level of the maximum CEV RNA synthesis activity (Fig. 3a, b) .
In agreement with the previous report by Semancik & Harper (1984) , more synthesis of CEV RNA occurred in the presence of MnC12 than with MgCI2. The maximum synthesis obtained with the optimum concentration of MgCI2 (10 mM) was only 40 to 50~ of the maximum obtained with the optimal concentration of MnCI: (1 mM). Although this enhancement of Mn 2÷ over Mg 2+ is not unique among RNA polymerase systems, it might have implications for the further processing of putative intermediate molecules of CEV in the replication scheme.
Polymerases are known to be metallo-enzymes requiring zinc (Zn 2÷) for their activity (Guilfoyle, 1983) . This characteristic can be useful to distinguish between a polymerization reaction and a process similar to end-labelling. The activity for CEV RNA synthesis was also sensitive to Zn 2+ chelators such as hydroxyquinoline and phenanthroline (Table 2) .
Response to ammonium sulphate
Contrasting with the results reported with nuclei-rich preparations (Semancik & Harper, 1984) in which the total RNA synthesis displayed a biphasic response curve to ammonium sulphate with the peak activity at 25 mM and a broad shoulder at 50 to 150 raM, the SSN had a monophasic response curve with an optimum for total RNA synthesis of 100 to 125 mM (Fig.  3 e) . CEV RNA synthesis displayed an optimum of 25 mM-ammonium sulphate. Although this property suggests the action of a system similar to that of RNA polymerase I, an alternative interpretation of an activity similar to RNA polymerase II acting on a deproteinized template (Semancik & Harper, 1984) should also be considered for consistency with the following inhibitor results.
RNA synthesis inhibitors
The synthesis of CEV RNA by the solubilized SSN extract was inhibited by up to 90~ with 4 ~tg/ml of ct-amanitin (Table 2 ). This result is consistent with the accumulated body of evidence which strongly supports the major involvement of an activity similar to that of RNA polymerase II in the process previously described with a variety of systems. In contrast, concentrations of up to 10 and 20 ~tg/ml of actinomycin D and 25 gg/ml of ethidium bromide inhibited viroid synthesis by only 25 to 30~. These values could be further complicated and potentially be lowered by the observation that the very presence of actinomycin D in the extraction medium affected the recovery of nucleic acids.
Sedimentation properties of the SSN products
In an attempt to study the products synthesized, the SSN fraction was incubated for RNA synthesis as described above and then fractionated by sucrose density gradient sedimentation. The nucleic acids of each fraction were phenol-extracted and analysed by PAGE. The distribution of the labelled (nascent) and unlabelled (native) CEV RNA is shown in Fig. 4 . Most of the labelled CEV RNA was found at the same density at which the CEV-synthesizing activity sedimented (Fig. 2b) , suggesting that the nascent CEV RNA remained associated with the replication complex even during sedimentation.
In addition, the ratio of circular to linear molecules is higher than the normal ratio observed in the gel system employed, suggesting that the circular molecules are a primary product of the replicative process. Some linear labelled CEV RNA sedimented at lower densities than the . Sucrose gradient sedimentation analysis of the CEV RNA products synthesized by the SSN fraction. After incubation of the SSN for RNA synthesis, the incubation mixture was sedimented through a sucrose gradient. Gradient fractions were phenol-extracted and analysed by sequential PAGE with the final denaturing gel silver-stained (upper) and autoradiographed (lower). Sedimentation is from right (top of gradient, fraction 11) to left (bottom of gradient, fraction 1) and the pellet (P) is also shown. An unfractionated (U) aliquot of the SSN is also presented. The density of fractions 3 and 4 containing the bulk of the labelled circular CEV RNA corresponds to the density of maximum CEV RNA synthesis activity in Fig. 2 (b) . The positions of the circular (CEV¢) and linear (CEVI) forms are indicated by the position of a standard (STD) preparation.
putative complex. This would suggest that when the R N A is liberated from the complex it is more susceptible to cleavage of the circular forms than is CEV bound in the replicating complex.
Kinetics of the synthesis of viroid structures
To analyse the kinetics of the reaction, the SSN was incubated for CEV R N A synthesis and aliquots were taken at different intervals, phenol-extracted and analysed by denaturing P A G E . To diminish the host R N A synthesis background, the incubation was made at 5 mM-MnC12. These conditions suppressed most of the host R N A synthesis but retained about 85~o of the CEV R N A synthesis. CEV R N A could be detected during the first 5 min and increased progressively with time to a maximum recovery by 25 to 45 min. A constant ratio of circular to linear viroid forms was maintained throughout the incubation, reinforcing the suggestion that circular viroid molecules are the primary products in the synthesis process.
DISCUSSION
Several approaches have been employed to study viroid replication. The most direct focuses on the detection of the viroid-related structures present in infected tissue. Based on the presence of viroid R N A molecules longer than unit length, a rolling circle mechanism for viroid replication has been postulated (Branch & Robertson, 1984) . However it has been speculated that oligomeric molecules could simply represent byproducts of an inefficient replication process (Hutchins et al., 1985) . In addition, the finding by Buzayan et al. (1986) that RNA complementary to the satellite RNA of tobacco ringspot virus could cleave and religate itself in a non-enzymic reaction increases the possibility of a head-to-tail ligation process to produce oligomeric molecules.
Another approach to the study of viroid replication focuses on viroid synthesis by cell extracts in vitro. Synthesis of viroid RNA by nuclear preparations has been well documented for CEV (Flores & Semancik, 1982; Semancik & Harper, 1984) , and PSTV (Takahashi & Diener, 1975; Spiesmacher et al., 1985) , but it has not been possible to define the components essential to the process. One of the main obstacles has been the high background that host RNA synthesis presents. To resolve this problem, the purification of a subnuclear fraction that retains the ability to synthesize viroid RNA has now been accomplished.
The use of the detergent sarkosyl has been effective in the isolation and characterization of transcriptional complexes and viral minichromosomes (Gariglio & Mousset, 1975; Gariglio et al., 1979; Shani et al., 1977) , and because of the differential sensitivity of transcriptional complexes to sarkosyl, it has been possible to study the different steps and requirements for the initiation and formation of the transcriptional unit (Hawley & Roeder, 1985; Kato et al., 1986) . The potential of the application of sarkosyl to study viroid replication is emphasized by the release of most of the CEV RNA-synthesizing activity to a soluble fraction, leaving the bulk of the host RNA synthetic activity still associated with nuclear structures that sediment at low speed. Furthermore the presence of sarkosyl during the incubation reaction reduces the probability of artefacts by inhibiting the reinitiation of transcription (Hawley & Roeder, 1985) .
Comparison of the properties of the viroid-synthesizing soluble complex contained in the SSN with those reported with intact nuclei confirms that sarkosyl solubilization of the replicative complex does not affect the basic characteristics of the CEV RNA synthesis reaction. In both cases, CEV RNA synthesis required similar optimum concentrations of divalent cations, MnCI 2 and MgCI2. The ionic strength optimum for the SSN, although being in the same range of ammonium sulphate concentrations, showed a more homogeneous pattern reflective of RNA polymerase II activity. Since the CEV RNA must be viewed as an unnatural template for the DNA-directed RNA polymerase II, the optimal reaction conditions of lower ionic strength may differ from reported values for host DNA templates.
Differences in the total RNA synthesis between the soluble fraction and the intact nuclei can be explained by the presence of the various forms of RNA polymerase in intact nuclei whereas the subnuclear fraction could be enriched for only one specific form of the enzyme. The RNA polymerase in the SSN displayed characteristics of an enzyme similar to RNA polymerase II, and it is conceivable that this observation may result from differences in the subnuclear location of the polymerases. Since RNA polymerase II is located in the nucleoplasm, whereas RNA polymerase I is found in the nucleoli, the release of the latter might require a more drastic treatment than 0.05 ~ sarkosyl will achieve. The inhibition obtained with inhibitors of RNA polymerases also characterizes the nature of the reaction. The overwhelming inhibition by ct-amanitin is consistent with previous reports employing intact cell and organelle systems and confirms the involvement of an activity similar to that of RNA polymerase II. Spiesmacher et al. (1985) reported a similar inhibition in the synthesis of PSTV in tomato nuclei; however the magnitude of this inhibition was underestimated in favour of a lower inhibition observed with actinomycin D. From this perspective, it was suggested that RNA polymerase I was responsible for the synthesis of PSTV plus strands. Nevertheless, it is well accepted that inhibition by ~-amanitin represents a more credible procedure with which to classify RNA polymerases than sensitivity to actinomycin D. The preferential binding of actinomycin D to GC-rich DNA, such as ribosomal genes, has been misinterpreted as a specific inhibition of RNA polymerase I by the inhibitor. Studies employing cloned rDNA genes have shown that no preferential inhibition of RNA polymerase I by actinomycin D exists (Sollner-Webb & Tower, 1986) .
Furthermore, the solubilization of the viroid-synthesizing activity from the nucleus as well as the insensitivity of the reaction to DNase I digestion suggests that a chromatin environment is not required for viroid RNA replication as suggested by Spiesmacher et al. (1985) . The reported sensitivity of PSTV to DNase digestion might be attributed to RNase contamination of the system, as observed in a more recent report (Tsagris et al., 1987) .
The sedimentation and kinetic analyses failed to verify the accumulation of linear viroid molecules as precursors of circular progeny. With the rapid detection of circular forms, it would seem that circular viroid molecules constitute a rapid primary product of this subnuclear fraction. This proposition would dictate that most of the nascent CEV molecules were rapidly processed into monomeric circular forms as soon as the growing nucleotide chain folded onto itself and acquired a stable secondary structure.
The solubilization of the replication complex by sarkosyl offers an approach to understand the components and mechanisms required for synthesis and processing of viroid RNA. The fact that the soluble fraction produces circular molecules indicates that the essential components for viroid replication are contained in the SSN preparation.
